Physiological role of cholecystokinin on gastric emptying and acid output in dogs
- PMID: 7956596
- DOI: 10.1007/BF02087643
Physiological role of cholecystokinin on gastric emptying and acid output in dogs
Abstract
We investigated the physiological role of cholecystokinin (CCK) on gastric emptying and acid secretion in seven conscious dogs with gastric cannulae. Two hundred milliliters of a 4% amino acid meal was given via the cannula, and both gastric emptying and acid output were measured concurrently using a dye-dilution technique. Gastric emptying of the liquid amino acid meal was exponential, and the acid output and plasma concentrations of CCK, gastrin, and somatostatin peaked within 30 min after the meal. Intravenous infusion of CCK-8 at 28 and 56 pmol/kg/hr but not 14 pmol/kg/hr increased plasma levels of the peptide and inhibited gastric emptying as well as acid output. Plasma gastrin was not affected significantly by the CCK infusion, whereas plasma somatostatin increased significantly in response to 56 pmol/kg/hr of CCK-8. Loxiglumide, 22 mumol/kg/hr, significantly enhanced gastric emptying and augmented acid output, as well as plasma gastrin response, whereas it abolished the postprandial rise in plasma somatostatin. We concluded that in dogs, CCK plays an important role in the physiologic regulation of postprandial gastric emptying of a liquid caloric meal and acid output. Its inhibitory effect on gastric acid secretion appears to be mediated, at least in part, by somatostatin.
Similar articles
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.Scand J Gastroenterol. 1994 Jul;29(7):583-90. doi: 10.3109/00365529409092476. Scand J Gastroenterol. 1994. PMID: 7939393 Clinical Trial.
-
Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.Gastroenterology. 1991 Aug;101(2):503-11. doi: 10.1016/0016-5085(91)90031-f. Gastroenterology. 1991. PMID: 2065926 Clinical Trial.
-
Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.Gastroenterology. 1994 Dec;107(6):1610-20. doi: 10.1016/0016-5085(94)90799-4. Gastroenterology. 1994. PMID: 7958670 Clinical Trial.
-
Effect of cholecystokinin on gastric motility in humans.Ann N Y Acad Sci. 1994 Mar 23;713:219-25. doi: 10.1111/j.1749-6632.1994.tb44068.x. Ann N Y Acad Sci. 1994. PMID: 8185162 Review.
Cited by
-
Inhibitory effects of cholecystokinin on postprandial gastric myoelectrical activity.Dig Dis Sci. 1995 Dec;40(12):2614-22. doi: 10.1007/BF02220450. Dig Dis Sci. 1995. PMID: 8536521 Clinical Trial.
-
Factors influencing the bioavailability of peroral formulations of drugs for dogs.Vet Res Commun. 1999 Nov;23(7):425-47. doi: 10.1023/a:1006321625243. Vet Res Commun. 1999. PMID: 10598074 Review.
-
Gastric emptying in OLETF rats not expressing CCK-A receptor gene.Dig Dis Sci. 1997 May;42(5):915-9. doi: 10.1023/a:1018860313674. Dig Dis Sci. 1997. PMID: 9149042
-
Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.Naunyn Schmiedebergs Arch Pharmacol. 2003 Apr;367(4):406-13. doi: 10.1007/s00210-003-0690-y. Epub 2003 Feb 26. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12690433
-
Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.Dig Dis Sci. 1999 Aug;44(8):1516-24. doi: 10.1023/a:1026642422375. Dig Dis Sci. 1999. PMID: 10492127